Rapid release of an easily accessible SARS-CoV-2 genome analysis pipeline [Funder: Genome BC, Illumina Canada]
- Funded by Other Funders (Canada)
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Funder
Other Funders (Canada)Principal Investigator
Dr and Dr and Dr and Mr Chanson Brumme, Zabrina Brumme, Julio Montaner, Don Kirkby…Research Location
CanadaLead Research Institution
University of British Columbia, Simon Fraser University, BC Centre for Excellence in HIV/AIDSResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Pathogen genomics, mutations and adaptations
Special Interest Tags
Innovation
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
This project will create a simple open-source software package that will help analyze viral genomic data from the COVID-19 pandemic. This tool will be created by adapting an existing data analysis tool, funded by Genome BC, that has proved successful in identifying drug resistance in other viral diseases including HIV and Hepatitis C. By making it extremely easy to use, the team hopes that this new tool will be rapidly adopted by scientists around the world, even in areas with limited computational infrastructure. It will fill a gap in the analysis pipeline for SARS-CoV-2 virus genomes. Within a week of launch it is estimated that this tool will enable end users to contribute genomic data about the novel coronavirus to public repositories. By sharing this data publicly, researchers around the globe will be able to utilize this data to track the origins, geographic spread and evolution of the virus in real time. This genomic data will also be useful for the development for medications and vaccines for use against the virus.